Shares of Molina Healthcare, Inc. (NYSE:MOH) have earned an average recommendation of “Buy” from the sixteen ratings firms that are presently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a sell recommendation, five have given a hold recommendation, eight have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $160.83.
MOH has been the topic of several research reports. BMO Capital Markets raised shares of Molina Healthcare from a “market perform” rating to an “outperform” rating and boosted their price objective for the company from $154.00 to $200.00 in a research report on Monday, June 3rd. Wells Fargo & Co raised shares of Molina Healthcare from a “market perform” rating to an “outperform” rating and set a $177.00 price objective on the stock in a research report on Friday, May 31st. ValuEngine cut shares of Molina Healthcare from a “sell” rating to a “strong sell” rating in a research report on Thursday, September 12th. Deutsche Bank initiated coverage on shares of Molina Healthcare in a research report on Thursday, September 12th. They issued a “buy” rating and a $145.00 price objective on the stock. Finally, Stephens set a $150.00 price objective on shares of Molina Healthcare and gave the company a “hold” rating in a research report on Wednesday, August 7th.
MOH traded up $1.58 during trading on Thursday, hitting $116.06. The company had a trading volume of 8,284 shares, compared to its average volume of 526,125. The company has a market capitalization of $7.26 billion, a PE ratio of 10.49, a PEG ratio of 1.05 and a beta of 1.20. Molina Healthcare has a one year low of $105.28 and a one year high of $159.00. The firm’s 50-day moving average price is $127.90 and its 200 day moving average price is $135.53. The company has a quick ratio of 1.73, a current ratio of 1.73 and a debt-to-equity ratio of 0.85.
In other Molina Healthcare news, Director Ronna Romney sold 375 shares of the business’s stock in a transaction dated Thursday, August 8th. The shares were sold at an average price of $131.63, for a total transaction of $49,361.25. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 0.77% of the company’s stock.
A number of large investors have recently modified their holdings of MOH. Advisors Preferred LLC bought a new stake in Molina Healthcare during the 2nd quarter worth about $37,000. Cornerstone Advisors Inc. lifted its position in Molina Healthcare by 3,577.8% during the 1st quarter. Cornerstone Advisors Inc. now owns 331 shares of the company’s stock worth $47,000 after buying an additional 322 shares in the last quarter. Stonebridge Capital Advisors LLC bought a new stake in Molina Healthcare during the 2nd quarter worth about $57,000. Financial Gravity Wealth Inc. lifted its position in Molina Healthcare by 35.0% during the 2nd quarter. Financial Gravity Wealth Inc. now owns 501 shares of the company’s stock worth $72,000 after buying an additional 130 shares in the last quarter. Finally, Bremer Bank National Association bought a new stake in Molina Healthcare during the 1st quarter worth about $87,000. 96.76% of the stock is currently owned by hedge funds and other institutional investors.
About Molina Healthcare
Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.
Further Reading: What Factors Can Affect Return on Equity?
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.